Many doctors find the information below valuable when deciding on the right PsA medication and treatment plan for their patients.Make the most of your next doctor’s appointmentby preparing to discuss the follo
View moretreatment options When to call a professional Call your doctor if you have symptoms of psoriatic arthritis. Prognosis The outlook for people with this disease varies. For some, psoriatic arthritis is a minor annoyance that requires medication only at times when symptoms are worse. However...
Background Rheumatoid arthritis (RA) and psoriatic arthritis (PsA) are chronic systemic illnesses that demand lifelong treatment. Adhesion to therapy is fundamental to achieve adequate disease control. Objectives We aimed to assess adherence to chronic therapy in RA and PsA patients and to identify ...
PsA treatment is tailored to your disease activity, your existing conditions, and your social life, says rheumatologist Paula Tanasa. Article Natural Remedies to Ease Aches Medication is your main weapon against psoriatic arthritis. But there’s plenty you can do to manage your symptoms on your ow...
The study was limited by its retrospective nature, and it did not take into account access to medication, which could have limited duration of treatment. Nielsen et al [25] used the same registry to retrospectively predict the most suitable biological therapy for patients with psoriasis. The ...
response to ustekinumab or clinical recurrence of psoriasis in the same location following ustekinumab withdrawal. In contrast, almost all non-lesional samples remained consistently negative at baseline, during treatment, and after withdrawal of study lead-in medication (Fig.2aand Supplementary Fig.5a)....
Discover RINVOQ, a once-daily medication for active psoriatic arthritis (PsA). See full Prescribing & Safety Information, and Boxed Warning.
Discover RINVOQ, a once-daily medication for active psoriatic arthritis (PsA). See full Prescribing & Safety Information, and Boxed Warning.
The sixth patient (with psoriatic arthritis) reported a history of LTBI, which was diagnosed 2 months before study inclusion. Although this patient did not have a positive LTBI test result at screening, the person was receiving isoniazid (INH) treatment at the time of study drug initiation. ...
In this study, our goal is to investigate the potential improvement in anxiety symptoms among psoriatic arthritis patients treated with upadacitinib. Such treatment is expected to not only slow down the progression of psoriatic arthritis but also alleviate anxiety, ultimately leading to improvements in...